Massachusetts painkiller developer to pay $2.75M in opioid settlement

By Rowan Walrath  | December 29, 2021

Painkiller developer Collegium Pharmaceutical has agreed to pay $2.75 million to settle more than two dozen opioid-related lawsuits.

Collegium (Nasdaq: COLL) also agreed to pay the state of Massachusetts $185,000 and stop marketing its opioids in person earlier this month, resolving allegations of what Attorney General Maura Healey described as “unfair and deceptive practices.”

READ MORE ON BIZJOURNALS.COM

By Rowan Walrath  | December 29, 2021

Painkiller developer Collegium Pharmaceutical has agreed to pay $2.75 million to settle more than two dozen opioid-related lawsuits.

Collegium (Nasdaq: COLL) also agreed to pay the state of Massachusetts $185,000 and stop marketing its opioids in person earlier this month, resolving allegations of what Attorney General Maura Healey described as “unfair and deceptive practices.”

READ MORE ON BIZJOURNALS.COM